Literature DB >> 10101735

Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats.

R M Bluthé1, N Castanon, F Pousset, A Bristow, C Ball, J Lestage, B Michaud, K W Kelley, R Dantzer.   

Abstract

Peripheral (i.p.) and central (i.c.v.) injections of lipopolysaccharide (LPS) have been shown to induce brain expression of proinflammatory cytokines and to depress social behaviour in rats, increase duration of immobility and induce body weight loss. To determine if the anti-inflammatory cytokine, interleukin-10 (IL-10) is able to modulate these effects, recombinant rat IL-10 was injected in the lateral ventricle of the brain (30, 100, 300 ng/rat) prior to i.p. or i.c.v. injection of LPS (250 micrograms/kg or 60 ng/rat, respectively). Social exploration was depressed for 6 h after i.p. LPS injection. This effect was attenuated by IL-10 (30 and 100 ng) 2 h after injection, whereas the highest dose of IL-10 blocked the depression of social interaction for 6 h after LPS injection. IL-10 produced the same effects on the increase of immobility although the results did not reach significance. Social exploration was depressed 3 h after i.c.v. LPS injection, and this was accompanied by increased immobility. These effects were totally blocked by i.c.v. IL-10 (300 ng/rat). Rats lost body weight after i.c.v. LPS, and this effect was attenuated by i.c.v. IL-10. These results indicate that IL-10 is able to modulate the production and/or action of central proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10101735     DOI: 10.1016/s0306-4530(98)00077-8

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  46 in total

Review 1.  Cognitive and behavioral consequences of impaired immunoregulation in aging.

Authors:  Angela W Corona; Ashley M Fenn; Jonathan P Godbout
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-20       Impact factor: 4.147

2.  Long-Term Microgliosis Driven by Acute Systemic Inflammation.

Authors:  Alissa Trzeciak; Yelena V Lerman; Tae-Hyoun Kim; Ma Rie Kim; Nguyen Mai; Marc W Halterman; Minsoo Kim
Journal:  J Immunol       Date:  2019-10-16       Impact factor: 5.422

Review 3.  Control of brain development, function, and behavior by the microbiome.

Authors:  Timothy R Sampson; Sarkis K Mazmanian
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

4.  Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol.

Authors:  A Suryanarayanan; J M Carter; J D Landin; A L Morrow; D F Werner; I Spigelman
Journal:  Neuropharmacology       Date:  2016-03-22       Impact factor: 5.250

5.  Modulation of Binge-like Ethanol Consumption by IL-10 Signaling in the Basolateral Amygdala.

Authors:  S Alex Marshall; Kyle H McKnight; Allyson K Blose; Donald T Lysle; Todd E Thiele
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-17       Impact factor: 4.147

Review 6.  Early attachment-figure separation and increased risk for later depression: potential mediation by proinflammatory processes.

Authors:  Michael B Hennessy; Terrence Deak; Patricia A Schiml-Webb
Journal:  Neurosci Biobehav Rev       Date:  2009-04-05       Impact factor: 8.989

7.  Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines.

Authors:  Christopher J Henry; Yan Huang; Angela M Wynne; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2008-09-12       Impact factor: 7.217

8.  Exaggerated expression of skeletal muscle-derived interleukin-6, but not TNFalpha, in mice lacking interleukin-10.

Authors:  Kimberly A Huey; Robert H McCusker; Keith W Kelley
Journal:  J Neuroimmunol       Date:  2008-06-18       Impact factor: 3.478

9.  Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide.

Authors:  Amy F Richwine; Nathan L Sparkman; Ryan N Dilger; Jessica B Buchanan; Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2009-03-09       Impact factor: 7.217

10.  Psychoneuroimmune implications of type 2 diabetes: redux.

Authors:  Jason C O'Connor; Daniel R Johnson; Gregory G Freund
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.